S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilarby The Uttam Hindu 10 March 2025 1:56 PM IST
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatmentby The Uttam Hindu 31 Jan 2025 2:47 PM IST
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatmentby The Uttam Hindu 31 Jan 2025 1:19 PM IST
New hope for rare genetic disorders: USFDA-Approved drug shows promiseby The Uttam Hindu 14 Nov 2024 1:32 PM IST
